[Immunosuppressive therapy of myasthenia gravis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000532:radiotherapy / Q000628:therapy*; D013934:Thymectomy
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents; D000324:Adrenocorticotropic Hormone
Immunsuppressive Therapie der Myasthenia gravis